HCA Healthcare (HCA) Earns Overweight Rating from Analysts at Stephens

Investment analysts at Stephens assumed coverage on shares of HCA Healthcare (NYSE:HCA) in a report released on Monday, The Fly reports. The firm set an “overweight” rating on the stock.

HCA has been the topic of a number of other research reports. Zacks Investment Research lowered HCA Healthcare from a “buy” rating to a “hold” rating in a report on Tuesday, December 11th. Credit Suisse Group increased their price objective on HCA Healthcare from $156.00 to $165.00 and gave the company an “outperform” rating in a report on Thursday, November 1st. Argus increased their price objective on HCA Healthcare from $150.00 to $155.00 and gave the company a “buy” rating in a report on Tuesday, November 6th. Finally, Jefferies Financial Group increased their price objective on HCA Healthcare to $155.00 and gave the company a “buy” rating in a report on Friday, September 21st. Two analysts have rated the stock with a sell rating, four have given a hold rating and eighteen have given a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus price target of $143.14.

HCA opened at $129.14 on Monday. HCA Healthcare has a fifty-two week low of $86.72 and a fifty-two week high of $147.42. The stock has a market cap of $44.16 billion, a PE ratio of 19.60, a PEG ratio of 1.04 and a beta of 0.69.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Tuesday, October 30th. The company reported $2.16 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.93 by $0.23. HCA Healthcare had a negative return on equity of 73.71% and a net margin of 6.82%. The company had revenue of $11.45 billion during the quarter, compared to the consensus estimate of $11.29 billion. During the same period last year, the business earned $1.13 EPS. The business’s quarterly revenue was up 7.1% on a year-over-year basis. As a group, equities research analysts anticipate that HCA Healthcare will post 9.33 earnings per share for the current fiscal year.

In other HCA Healthcare news, SVP Kathryn A. Torres sold 820 shares of the firm’s stock in a transaction that occurred on Tuesday, November 13th. The stock was sold at an average price of $142.36, for a total value of $116,735.20. Following the sale, the senior vice president now owns 4,237 shares of the company’s stock, valued at approximately $603,179.32. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Michael S. Cuffe sold 4,943 shares of the firm’s stock in a transaction that occurred on Friday, November 9th. The stock was sold at an average price of $141.90, for a total value of $701,411.70. Following the completion of the sale, the insider now owns 33,240 shares of the company’s stock, valued at approximately $4,716,756. The disclosure for this sale can be found here. Insiders sold a total of 16,763 shares of company stock worth $2,346,147 in the last ninety days. Insiders own 2.80% of the company’s stock.

Several hedge funds have recently made changes to their positions in HCA. Dimensional Fund Advisors LP lifted its position in shares of HCA Healthcare by 0.4% in the 2nd quarter. Dimensional Fund Advisors LP now owns 525,312 shares of the company’s stock worth $53,900,000 after acquiring an additional 1,952 shares during the period. FMR LLC lifted its position in shares of HCA Healthcare by 54.9% in the 2nd quarter. FMR LLC now owns 5,488,273 shares of the company’s stock worth $563,097,000 after acquiring an additional 1,944,961 shares during the period. Raymond James & Associates lifted its position in shares of HCA Healthcare by 8.0% in the 2nd quarter. Raymond James & Associates now owns 81,483 shares of the company’s stock worth $8,360,000 after acquiring an additional 6,039 shares during the period. Voya Investment Management LLC lifted its position in shares of HCA Healthcare by 5.7% in the 2nd quarter. Voya Investment Management LLC now owns 102,216 shares of the company’s stock worth $10,488,000 after acquiring an additional 5,525 shares during the period. Finally, Bank of America Corp DE lifted its position in shares of HCA Healthcare by 67.9% in the 2nd quarter. Bank of America Corp DE now owns 639,790 shares of the company’s stock worth $65,642,000 after acquiring an additional 258,667 shares during the period. Institutional investors own 69.82% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Featured Article: Bollinger Bands

The Fly

Analyst Recommendations for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply